Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease.
OBJECTIVE
Tumor necrosis factor-alpha (TNFalpha) is a potent proinflammatory cytokine. Through its effects on lipid metabolism and endothelial function, TNFalpha is involved in cardiovascular disease (CVD). We have studied two polymorphisms in the promoter region of the TNFalpha gene (TNF -308G/A and TNF -238G/A) in end-stage renal disease (ESRD) patients with and without CVD. The aim was to assess the association of these polymorphisms with ESRD and cardiovascular comorbidity in hemodialyzed patients.


METHODS
A total of 603 patients with ESRD treated with hemodialysis (382 patients with CVD) and 325 healthy control subjects were genotyped for the TNF -308G/A and TNF -238G/A ploymorphisms by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) procedure.


RESULTS
The A allele of the TNF -308 polymorphism was more frequent in the ESRD group than in control individuals. The odds ratio (OR) for the risk allele was 2.05 (95% CI 1.48, 2.84). In the subgroup of ESRD patients with CVD, the OR was 5.76 (95% CI 3.67, 9.03) relative to ESRD patients without CVD. There was no association observed between the TNF -238 polymorphism and renal failure or CVD in ESRD patients.


CONCLUSIONS
Our results demonstrate for the first time that the A allele of the TNF -308 polymorphism is associated with CVD in hemodialyzed ESRD patients. If confirmed in prospective studies, it may be a predictor of increased susceptibility to CVD in these patients.
Buraczynska
Monika
M
Laboratory for DNA Analysis and Molecular Diagnostics, Department of Nephrology, Skubiszewski Medical University, Lublin, Poland. monika.buraczynska@am.lublin.pl
Mierzicki
Piotr
P
Buraczynska
Kinga
K
Dragan
Michał
M
Ksiazek
Andrzej
A
D002318:Cardiovascular Diseases / Q000150:complications* / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D006435:Renal Dialysis; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D014409:Tumor Necrosis Factor-alpha
Semin Dial. 2005 Jul-Aug;18(4):322-30
16076356
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9
9096369
J Immunol. 1995 Jan 15;154(2):882-92
7814891
Am J Kidney Dis. 1998 Nov;32(5):834-41
9820457
Kidney Int. 1998 Jul;54(1):236-44
9648084
Eur J Clin Invest. 1998 Jan;28(1):59-66
9502188
Mol Immunol. 1997 Apr;34(5):391-9
9293772
Genes Immun. 2004 Jun;5(4):267-73
15057268
Nephrol Dial Transplant. 2004 May;19(5):1058-68
15004266
Kidney Int. 2005 Apr;67(4):1216-33
15780075
J Inflamm. 1995-1996;46(1):42-50
8832971
Nephrol Dial Transplant. 2005 Dec;20(12):2733-8
16141456
Eur J Clin Invest. 2001 Oct;31(10):843-51
11737221
Kidney Int. 2003 Aug;64(2):616-22
12846758
Clin Chim Acta. 2006 Aug;370(1-2):152-7
16545788
Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233-7
2105500
Tissue Antigens. 2003 May;61(5):393-7
12753658
Clin Chem Lab Med. 2003 Apr;41(4):511-6
12747595
Kidney Int. 2004 Jun;65(6):2380-9
15149351
Kidney Int. 2005 Oct;68(4):1413-8
16164615
Kidney Int. 2000 Aug;58(2):783-9
10916103
Am J Kidney Dis. 2000 Nov;36(5):925-33
11054348
Vascul Pharmacol. 2006 May;44(5):377-83
16581306
Kidney Int. 2004 Apr;65(4):1449-60
15086488
Nephrol Dial Transplant. 1997 Apr;12 (4):691-3
9140995
Immunogenetics. 1997;45(3):188-94
8995185
N Engl J Med. 1996 Jun 27;334(26):1717-25
8637518
Kidney Int Suppl. 2000 Apr;75:S7-14
10828755
Atherosclerosis. 2001 Feb 15;154(3):691-7
11257271
N Engl J Med. 1999 Jan 14;340(2):115-26
9887164
Nephrology (Carlton). 2005 Oct;10 Suppl:S32-6
16174285
Microsc Res Tech. 2000 Aug 1;50(3):216-28
10891887
Kidney Int. 2000 Feb;57(2):632-8
10652041
Kidney Int. 2006 Apr;69(8):1424-30
16557227
Hemodial Int. 2004 Apr 1;8(2):118-29
19379407
Metabolism. 2000 Aug;49(8):1021-4
10954020
Adv Perit Dial. 1999;15:82-6
10682077
Proc Assoc Am Physicians. 1999 Jul-Aug;111(4):290-8
10417736
J Invest Dermatol. 2002 Jan;118(1):155-63
11851889
Ann Rheum Dis. 2005 Mar;64(3):457-61
15708894